Successful fatherhood of males with tyrosine kinase inhibitor-resistant chronic myeloid leukemia taking olverembatinib
Abstract As life expectancy in patients with chronic myeloid leukemia (CML) approaches that of the general population, fertility preservation has become a critical quality-of-life consideration, especially for younger patients. Although third-generation (3G) tyrosine kinase inhibitors (TKIs), such a...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer
2025-11-01
|
| Colecção: | Annals of Hematology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/s00277-025-06722-2 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|